Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

Update Il y a 4 ans
Reference: NCT00184613

Woman and Man

  • | Country :
  • Denmark
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This trial is conducted in Europe. The objective of the study is to investigate the effect and safety of continously basal delivered insulin aspart given by a pump versus once daily injection of insulin glargine.


Inclusion criteria

  • diabetes ,Diabetes Mellitus, Type 2 ,Delivery Systems

Links